フォローフィードコミュニティでトレーダーや投資家とつながりましょう.
包括的なオプション データを調査し、オプション フローで高度なフィルターを使用します.
ターミナル モニターで株式と資産のウォッチリストを整理および監視します
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 15 ...
UNITED STATESSECURITIES AND EXCHANGE COMMISSIONWashington, D.C. 20549FORM 25 NOTIFICATION OF REMOVAL FROM LISTING AND/OR REGISTRATION UNDER...
false 0001837997 0001837997 2022-08-25 2022-08-25 0001837997 us-gaap:CommonStockMember 2022-08-25 2022-08-25 0001837997 us-gaap:WarrantMember...
Isleworth Healthcare Acquisition Corp. Announces Cancellation of Special Meeting of Shareholders, Redemption of Public Shares and Subsequent...
falseQ20001837997--12-31P15Y 0001837997 2021-12-31 0001837997 2022-06-30 0001837997 2021-01-01 2021-06-30 0001837997 2022-01-01 2022-06-30...
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549...
ISLEWORTH AND CYTOVIA TERMINATE MERGER AGREEMENT PR Newswire ST. PETERSBURG, Fla., June 30, 2022 ST. PETERSBURG, Fla., June 30, 2022 /PRNewswire/...
false 0001837997 0001837997 2022-06-30 2022-06-30 0001837997 isle:CommonStockParValue0.0001PerShare2Member 2022-06-30 2022-06-30 0001837997...
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K ...
Filed by Isleworth Healthcare Acquisition Corp. pursuant to Rule 425 under the Securities Act of 1933, as amended and deemed filed...
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT...
false 0001837997 0001837997 2022-06-07 2022-06-07 0001837997 isle:CommonStockParValue0.0001PerShare2Member 2022-06-07 2022-06-07 0001837997...
Cytovia Therapeutics presents antitumor activity of its CD38-Targeting Flex-NK™ Cell Engager antibody at EHA...
ご覧いただいた銘柄が下記のボックス内に表示されますので、過去閲覧した銘柄情報に簡単にアクセスすることができます。
顧客サポート: +44 (0) 203 8794 460 | support@advfn.com
ADVFNのサービスをご利用いただくには、利用規約